His collaboration with biophysicist Francis Crick on the molecular key to all living organisms would make him one of the most ...

Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

Patients who followed an AI coach from an app on their phone cut their risk of developing diabetes as much as those visiting ...

Israel's swift vaccination rollout has made it the largest real-world study of Pfizer Inc's COVID-19 vaccine. Results are ...

A recent poll by AP/NORC found that 57 percent of Americans were "extremely" or "very" concerned about rising health care costs.

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...

“In people who have diabetes, when they’re on GLP-1s, they experience an early increase in the risk of diabetic retinopathy,” ...

Adult and pediatric experts from @HopkinsMedicine, @EndoHopkins, and @HopkinsKids are available all month to raise diabetes awareness and discuss how the disease impacts adults and children.

People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including ...

People with type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a ...